AmpliPhi BioSciences Corporation
(NYSE Amex Equities : APHB)

( )
APHB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.27%93.671.3%$1008.13m
BIIBBiogen Inc.
0.61%230.211.3%$687.10m
AMGNAmgen Inc.
1.93%179.761.3%$470.05m
GILDGilead Sciences, Inc.
1.89%63.040.9%$441.53m
ILMNIllumina, Inc.
0.93%322.063.5%$285.16m
REGNRegeneron Pharmaceuticals, Inc.
3.03%344.142.6%$275.35m
VRTXVertex Pharmaceuticals Incorporated
4.07%175.371.9%$247.10m
ALXNAlexion Pharmaceuticals, Inc.
2.64%132.372.0%$175.19m
EXASExact Sciences Corporation
3.61%93.9425.3%$160.74m
SRPTSarepta Therapeutics, Inc.
3.78%118.0914.7%$144.55m
AAgilent Technologies, Inc.
-0.04%75.541.6%$142.04m
ONCESpark Therapeutics, Inc.
0.00%110.6011.2%$133.55m
INCYIncyte Corporation
2.38%75.412.5%$98.69m
IONSIonis Pharmaceuticals, Inc.
3.25%75.008.3%$95.31m
BMRNBioMarin Pharmaceutical Inc.
2.74%86.004.3%$93.68m

Company Profile

AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.